Daniel Dornbusch, CEO of Excision BioTherapeutics, sits down with Neil to discuss his company’s efforts to develop CRISPR-based therapies to cure HIV and other viral infectious diseases.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
